July 9, 2013: by longevinex.com
Las Vegas, NV (July 9, 2013) – In an effort to help ensure its product is not removed from the marketplace by onerous requirements stipulated by regulatory agencies or by covert efforts to undermine its product quality, Longevinex® announces today its proprietary red wine anti-aging capsules have passed stringent sub-acute toxicity testing, a requirement for further human testing.
Longevinex® red wine capsules did not produce significant toxic side effects or mortality in laboratory mice at human equivalent doses of 3500 and 7000 milligrams per day (~10-20 oral capsules/day) in testing conducted under the supervision of Hannah R. Vasanthi PhD, at the Department of Biotechnology, Pondicherry University, India. A complete report was published in the journal of Food & Chemical Toxicology.
March 13, 2013: by Bill Sardi
…. mice fed a normal-calorie diet did not live longer, the initial experiment to show the primary gene target for resveratrol was flawed and a huge dose of this red wine molecule barely improved measurable health parameters among metabolic disease (diabetes) patients and induced kidney failure among terminal cancer patients, causing the sponsor of a resveratrol-based drug to halt all research and development.